RIGHT TO TRY INDIVIDUALIZED TREATMENTS ACT

Summary

The bill lets people with life‑threatening or severely disabling illnesses ask manufacturers for personalized investigational drugs or devices made to match their genetic profile. Patients must give detailed written consent and may be charged for the treatment, while insurers are not required to pay for it. The law also protects patients’ estates from debt and shields doctors from discipline for recommending such treatments.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share